Vor BiopharmaVOR
那斯達克 · USD
0
0
(0%)
收盤 01/01 08:00 (UTC+8)
盤後
14.34
+0.01
(+0.07%)
01/01 08:00 (UTC+8)
Vor BiopharmaVOR
0
0
(0%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 35,160 | 35,960 | 28,107 | 274,284 | 33,291 | 31,311 | 28,513 | 29,035 | - | 28,124 |
研發費用 | 17,595 | 19,190 | 14,142 | 261,499 | 26,701 | 25,348 | 21,817 | 21,823 | 24,322 | 20,897 |
推銷及管理費用 | 17,565 | 16,770 | 13,965 | 12,785 | 6,590 | 5,963 | 6,696 | 7,212 | 8,004 | 7,227 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -35,160 | -35,960 | -28,107 | -274,284 | -33,291 | -31,311 | -28,513 | -29,035 | -32,326 | -28,124 |
其他收入及費用 | -184,425 | 1,758,818 | -784,577 | - | 805 | 599 | 954 | 1,196 | 1,522 | 1,863 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -219,585 | 1,722,858 | -812,684 | -1,573,669 | -32,486 | -30,712 | -27,559 | -27,839 | -30,804 | -26,261 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -219,585 | 1,722,858 | -812,684 | -1,573,669 | -32,486 | -30,712 | -27,559 | -27,839 | -30,804 | -26,261 |
基本每股稅後盈餘(元) | -5.11 | 63.95 | -121.63 | -12.56 | -0.26 | - | -0.40 | -0.41 | -0.45 | - |
稀釋每股稅後盈餘(元) | -5.11 | 307.61 | -121.31 | -12.58 | -0.26 | -0.44 | -0.40 | -0.41 | -0.45 | -0.38 |
基本平均股數(千股) | 43011.00 | - | 6681.00 | 125271.00 | 124824.00 | - | 68469.00 | 68299.00 | 68030.00 | - |
稀釋平均股數(千股) | 43011.00 | - | 6681.00 | 125271.00 | 124824.00 | - | 68469.00 | 68299.00 | 68030.00 | - |
還原基本每股稅後盈餘(元) | -5.11 | 63.95 | -121.63 | -251.20 | -5.21 | - | -8.05 | -8.20 | -9.00 | - |
還原稀釋每股稅後盈餘(元) | -5.11 | 307.61 | -121.31 | -251.59 | -5.21 | -8.78 | -8.05 | -8.20 | -9.00 | -7.60 |
還原基本平均股數(千股) | 43,011 | - | 6,681 | 6,263 | 6,241 | - | 3,423 | 3,414 | 3,401 | - |
還原稀釋平均股數(千股) | 43,011 | - | 6,681 | 6,263 | 6,241 | - | 3,423 | 3,414 | 3,401 | - |
EBITDA(千元) | -220,045 | 1,722,847 | -812,693 | -1,571,632 | -31,672 | -29,859 | -26,719 | -27,299 | -30,658 | -26,355 |